American Diabetes Association

Skip to Main Content

Table 1—

Comparison of original model and patient preferences for glucose control treatments and microvascular complications

Sources	Utilities for complications					Utilities for treatments
		Blindness	Chronic renal failure with hemodialysis	Amputation	Conventional glucose control	Intensive glucose control
		Blindness	Chronic renal failure with hemodialysis	Amputation	Conventional glucose control					Oral medications	Insulin
Original model utilities (refs. 17–19)	0.69	0.61	0.80	1	1	1
Patient utilities	0.39 (0.36–0.42)	0.36 (0.34–0.39)	0.45 (0.42–0.48)	0.76 (0.74–0.78)	0.77 (0.75–0.80)	0.64 (0.61–0.67)

Sources	Utilities for complications					Utilities for treatments
		Blindness	Chronic renal failure with hemodialysis	Amputation	Conventional glucose control	Intensive glucose control
		Blindness	Chronic renal failure with hemodialysis	Amputation	Conventional glucose control					Oral medications	Insulin
Original model utilities (refs. 17–19)	0.69	0.61	0.80	1	1	1
Patient utilities	0.39 (0.36–0.42)	0.36 (0.34–0.39)	0.45 (0.42–0.48)	0.76 (0.74–0.78)	0.77 (0.75–0.80)	0.64 (0.61–0.67)

Data are means (95% CI), unless otherwise indicated.